How Ketamine Providers Handle Adverse Reactions During Treatment

How Ketamine Providers Handle Adverse Reactions During Treatment

One of the most practical questions to ask before starting ketamine therapy is what happens if something goes wrong during a session. Adverse reactions during ketamine treatment range from mild and expected, temporary dissociation, elevated heart rate, nausea, to more serious situations that require immediate clinical attention. How a provider prepares for and responds to those moments says a great deal about the quality of care you can expect.

This guide walks through the types of reactions providers watch for, the monitoring and response protocols that distinguish well-run clinics from those with thinner safety infrastructure, and the specific questions worth raising before you commit to a treatment plan.

What Counts as an Adverse Reaction?

Ketamine produces a range of predictable effects that are not emergencies but do require monitoring. These include dissociation, perceptual changes, elevated blood pressure and heart rate, nausea, dizziness, and anxiety during or shortly after a session. Most patients experience at least some of these effects, particularly at higher doses used for psychiatric indications.

Serious adverse reactions are less common but do occur. They include severe cardiovascular changes (marked hypertension, arrhythmia), significant respiratory depression, prolonged emergence agitation, intense psychological distress, and, rarely, loss of consciousness. Patients with certain pre-existing conditions, such as uncontrolled hypertension or a history of psychosis, face elevated risk for some of these outcomes, which is why screening before treatment matters.

The FDA's prescribing information for esketamine (Spravato) requires a Risk Evaluation and Mitigation Strategy (REMS) that mandates monitoring for at least two hours after each dose specifically because of dissociation and sedation risks. While that REMS applies formally to the esketamine nasal spray formulation, it reflects the safety rationale that informs how careful providers approach IV and other ketamine modalities as well.

Core Safety Infrastructure at Reputable Providers

Not all ketamine clinics operate the same way. The difference in how providers handle adverse reactions often comes down to their physical setup, staffing model, and how they screen patients before treatment begins.

Credible ketamine providers generally maintain several baseline safety elements. Continuous monitoring equipment, at minimum pulse oximetry and blood pressure monitoring throughout a session, is standard at in-person clinics offering IV ketamine. The American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3) and anesthesiology guidelines for procedural sedation both point to the need for this level of monitoring when dissociative doses are administered.

Staffing is equally important. A trained clinician, not a front desk coordinator, should be present or immediately accessible during a session, able to recognize and respond to cardiovascular or respiratory changes. At in-person IV infusion centers, this typically means a physician, nurse practitioner, or registered nurse with ACLS (Advanced Cardiovascular Life Support) certification. You can read more about what to verify in advance in our guide to ketamine provider safety protocols what to verify before treatment.

Emergency equipment, oxygen, reversal agents where applicable, and a clear path to emergency medical services, should be present and maintained. Providers who cannot clearly describe their emergency response procedures when you ask directly are worth approaching with caution.

How At-Home and Telehealth Models Differ

A growing number of services offer ketamine through telehealth-supervised at-home programs, typically using lower-dose sublingual or troches formulations. These models involve different safety trade-offs that are worth understanding before comparing them with in-person clinic care.

In an at-home model, the patient is not in a clinical environment. There is no staff physically present to monitor vital signs, respond to cardiovascular events, or intervene if a serious adverse reaction occurs. Telehealth providers typically require a support person to be present during sessions and conduct video check-ins, but the response capacity during an actual emergency is limited compared to a staffed clinic.

The doses used in at-home programs are generally lower and associated with a different risk profile than IV infusion doses. That said, patients with certain medical histories, cardiac conditions, uncontrolled blood pressure, history of psychosis or mania, may face elevated risk even at lower doses, and some are not appropriate candidates for at-home care regardless of the convenience.

If you are weighing care models, our oral ketamine experience guide and IV infusion experience guide describe what sessions in each setting typically feel like, which can help you think through which environment fits your situation.

The Role of Pre-Treatment Screening in Preventing Adverse Reactions

How a provider screens patients before treatment is one of the clearest signals of how seriously they take adverse reaction risk. Thorough screening does not eliminate risk, but it reduces the likelihood of serious events by identifying contraindications and adjusting protocols accordingly.

A careful intake process typically includes a review of your full medical history, current medications, and prior psychiatric diagnoses. Ketamine can raise blood pressure significantly, so uncontrolled hypertension is a common concern. It may also trigger dissociative or manic episodes in people with certain psychiatric histories, which is why some providers will not administer ketamine to patients with a history of psychosis or active mania without specific safeguards in place.

Drug interactions matter as well. Certain medications, including some MAOIs, carry interaction risks with ketamine that require review before treatment. The published clinical literature on ketamine pharmacology has grown substantially over the past decade, and providers who stay current with it are better positioned to identify risks specific to your situation.

If a provider's intake process feels brief or does not ask about your medical history in depth, that is worth noting. You can find a fuller discussion of what the preparation phase typically involves in our guide to preparing for treatment.

What to Ask a Provider Before Your First Session

Most providers expect prospective patients to ask questions about safety. If a clinic discourages or deflects these questions, that itself is informative. The goal is not to catch anyone out, it is to give yourself enough information to make a thoughtful decision.

Ask specifically about what happens if your blood pressure rises during a session, what the process is if you become severely distressed, and who makes the call to stop treatment or escalate to emergency care. Ask about the credentials of whoever will be present during your session. Ask what happens after the session ends before you are allowed to leave.

You should also ask about their experience with patients who have a medical or psychiatric history similar to yours. A provider who has worked with patients managing the same comorbidities you have will have more calibrated judgment about your specific risk profile than one encountering your situation for the first time.

After a Difficult Session: What Follow-Up Should Look Like

Even when a session stays within expected parameters, some patients have experiences that feel destabilizing, emotionally intense, frightening, or confusing in the hours and days that follow. How providers handle the period after a difficult session matters for both safety and treatment outcomes.

Good follow-up practice includes a check-in contact the day after treatment, a clear protocol for what patients should do if symptoms persist or worsen, and access to a clinician who can help contextualize a difficult experience. This is especially relevant for patients undergoing ketamine for depression or PTSD, where psychological material surfaced during a session may need processing with a therapist.

Some providers offer integrated therapy sessions alongside ketamine treatment; others recommend patients work with an outside therapist. Either approach can be appropriate. What matters is that there is a plan for follow-up support and that you know how to reach someone if a session leaves you in a difficult place. Our maintenance treatment guide covers what ongoing care typically involves once an initial course of treatment is complete.